medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Número 6

<< Anterior

Ann Hepatol 2012; 11 (6)


Increased mortality in chronic HCV infection

Ridruejo E

Idioma: Ingles.
Referencias bibliográficas: 18
Paginas: 967-968
Archivo PDF: 62.78 Kb.


FRAGMENTO

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lavanchy D. The global burden of hepatitis C. Liver Int 2009; 29(Suppl. 1): 74-81.

  2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5: 558-67.

  3. Institute of Medicine. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Washington, DC: The National Academic Press; 2010.

  4. Mitchell AE, Colvin HM, Palmer Beasley R. Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology 2010; 51: 729-33.

  5. Verna EC, Brown RS Jr. Hepatitis C virus and liver transplantation. Clin Liver Dis 2006; 10: 919-40.

  6. Kanwal F, Hoang T, Kramer JR, et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology 2011; 140: 1182-8.

  7. Davis GL, Alter MJ, El-Serag H, et al. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010; 138: 513-21.

  8. Lee MH, Yang HI, Lu SN, et al; for the REVEAL-HCV Study Group. Chronic hepatitis C virus infection increases mortality from hepatic and extra-hepatic diseases: a community- based long-term prospective study. J Infect Dis 2012; 206: 469-77.

  9. Guiltinan AM, Kaidarova Z, Buster B, et al. Increased allcause, liver and cardiac mortality among hepatitis C virus seropositive blood donors. Am J Epidemiol 2008; 167: 743-50.

  10. Amin J, Law MG, Bartlett M, et al. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006; 368: 938-45.

  11. Ly KN, Xing J, Klevens M, et al. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 2012; 156: 271-8.

  12. Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N. Assessment of long-term outcomes of community- acquired hepatitis C infection in a cohort with sera stored from 1971 to 1973. Hepatology 2000; 32: 582-7.

  13. Seeff LB, Hollinger BF, Alter HJ, et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B and type C hepatitis: a national heart, lung and blood institute collaborative study. Hepatology 2001; 38: 455-63.

  14. Uto H, Stuver SO, Hayashi K, et al. Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study. Hepatology 2009; 50: 393-9.

  15. Wiese M, Grungreiff K, Guthoff W, Lafrenz M, et al. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany-a 25 year multicenter study. J Hepatol 2005; 43: 590-8.

  16. Harris HE, Ramsey ME, Andrews NJ. Survival of a national cohort of hepatitis C virus infected patients, 16 years after exposure. Epidemiol Infect 2006; 134: 472-7.

  17. Grebely J, Dore GJ. What is killing people with hepatitis C virus infection? Sem Liver Dis 2011; 31: 331-3.

  18. Ng V, Saab S. Effects of a sustained virologic response on outcomes of patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2011; 9: 923-30.




2020     |     www.medigraphic.com